Market Research Logo

Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes) - Global Forecast to 2023

Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes) - Global Forecast to 2023
“The hepatitis test solution/diagnosis market is projected to register a CAGR of 4.9%.”
The hepatitis test solution/diagnosis market is expected to reach USD 3.37 billion by 2023 from USD 2.66 billion in 2018, growing at a CAGR of 4.9% during the forecast period. The growth of this market can be attributed to the high burden of hepatitis worldwide, benefits offered by point of care instruments & kits, and initiatives taken by government and non-government organizations. However, lack of mandate for NAT in developing countries and the high cost of NAT test are expected to restrain the growth of this market during the forecast period.

“The rapid diagnostics test segment of the hepatitis test solution/diagnosis market, by technology, is projected to grow at the highest CAGR in 2018.”
By technology, the hepatitis test solution/diagnosis market is segmented into ELISA, rapid diagnostics test, PCR, INAAT, and other technologies. RDT is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the low cost of this test type, its high analytical sensitivity, and its ability to detect all known 11 subtypes of HBsAg.

“The hepatitis B segment is expected to account for the largest share of the market, by disease type, in 2018.”
The market is classified on the basis of disease type into hepatitis B, hepatitis C, and other hepatitis disease. In terms of value, the hepatitis B segment is expected to account for the largest share of the market in 2018. This can primarily be attributed to the rising prevalence of hepatitis B, availability of a large number of hepatitis B diagnostic tests, and the increasing adoption of NAT test in HBV blood screening.

“North America to dominate the market in 2018.”
North America is expected to account for the largest share of the global hepatitis test solution/diagnosis market in 2018. This is primarily attributed to factors such as rising adoption of advanced technologies, developed healthcare systems in the US and Canada, and the presence of a large number of leading national clinical laboratories. Followed by North America, Europe is expected to account for the second-largest share of the global hepatitis test solution/diagnosis market in 2018.

Break-up profile of primaries:
By Company Type- Tier 1-32%, Tier 2-42% and Tier 3-26%
By Designation-C-level-23%, D-level-35% and Others-42%
By Region-North America-39%, Europe-25%, Asia Pacific-26%, and RoW-10%

Abbott Laboratories (US), Roche (Switzerland), Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), Danaher (US), bioMérieux (France), and Grifols (Spain) are some of the key players operating in this market.

Research Coverage:
The hepatitis test solution/diagnosis market studied in this report is segmented by disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches; expansions; agreements, partnerships, and collaborations; and acquisitions. It also profiles the key players and their core competencies within the hepatitis test solution/diagnosis market.

Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on portfolios offered by the top players in the global hepatitis test solution/diagnosis market. The report analyzes the hepatitis test solution/diagnosis market by disease type, technology, end user, and region.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the hepatitis test solution/diagnosis market

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for hepatitis test solution/diagnosis products across regions.

Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global hepatitis test solution/diagnosis market

Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global hepatitis test solution/diagnosis market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • YEARS COVERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • PRIMARY DATA
      • KEY DATA FROM PRIMARY SOURCES
      • KEY INDUSTRY INSIGHTS
    • SECONDARY DATA
    • KEY DATA FROM SECONDARY SOURCES
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • HEPATITIS TESTING: MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: HEPATITIS TESTING MARKET, BY DISEASE TYPE (2018)
    • HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2018 VS. 2023
    • HEPATITIS TESTING MARKET, BY END USER, 2016-2023
  • MARKET OVERVIEW
    • INTRODUCTION
      • DRIVERS
        • Table GLOBAL HEPATITIS PREVALENCE (MILLION PEOPLE APPROX.), 2015
        • Table INCREASE IN VOLUNTARY NON-REMUNERATED BLOOD DONATIONS AND TOTAL BLOOD DONATIONS, 2008-2013
      • RESTRAINTS
      • OPPORTUNITIES
  • HEPATITIS TESTING MARKET, BY DISEASE TYPE
    • INTRODUCTION
      • Table HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2016-2023 (USD MILLION)
    • HEPATITIS B (HBV)
      • Table HEPATITIS B TESTING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS B TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • HEPATITIS C (HCV)
      • Table HEPATITIS C TESTING MARKET, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS C TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER HEPATITIS DISEASES
      • Table HEPATITIS TESTING MARKET FOR OTHER DISEASES, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • HEPATITIS TESTING MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
    • ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
      • Table HEPATITIS TESTING MARKET FOR ELISA, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR ELISA, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET FOR ELISA, BY COUNTRY, 2016-2023 (USD MILLION)
    • RAPID DIAGNOSTIC TESTS (RDT)
      • Table HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS, BY COUNTRY, 2016- 2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS, BY COUNTRY, 2016-2023 (USD MILLION)
    • POLYMERASE CHAIN REACTION (PCR)
      • Table HEPATITIS TESTING MARKET FOR PCR, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR PCR, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET FOR PCR, BY COUNTRY, 2016-2023 (USD MILLION)
    • ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
      • Table HEPATITIS TESTING MARKET FOR INAAT, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR INAAT, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET FOR INAAT, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • HEPATITIS TESTING MARKET, BY END USER
    • INTRODUCTION
      • Table HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • HOSPITAL & DIAGNOSTIC LABORATORIES
      • Table HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABS, BY COUNTRY, 2016-2023 (USD MILLION)
    • BLOOD BANKS
      • Table HEPATITIS TESTING MARKET FOR BLOOD BANKS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR BLOOD BANKS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET FOR BLOOD BANKS, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER END USERS
      • Table HEPATITIS TESTING MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • HEPATITIS TESTING MARKET, BY REGION
    • INTRODUCTION
      • Table HEPATITIS TESTING MARKET, BY REGION, 2016-2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • US
        • Table HAV AND HBV VACCINATION COVERAGE: US (2014-2016)
        • Table US: HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2016-2023 (USD MILLION)
        • Table US: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table US: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • CANADA
        • Table CANADA: HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2016-2023 (USD MILLION)
        • Table CANADA: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table CANADA: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: HEPATITIS TESTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table EUROPE: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table GERMANY: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • UK
        • Table UK: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table UK: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
        • Table ROE: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • ASIA PACIFIC
      • Table ESTIMATED PREVALENCE OF CHRONIC HBV AND HCV: ASIA PACIFIC
      • Table ASIA-PACIFIC: COST COVERAGE FOR DIAGNOSIS OF CHRONIC VIRAL HEPATITIS
      • Table APAC: HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2016-2023 (USD MILLION)
      • Table APAC: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table APAC: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2016-2023 (USD MILLION)
      • Table ROW: HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
      • Table ROW: HEPATITIS TESTING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • MARKET OVERVIEW
    • MARKET RANKING ANALYSIS, 2017
      • Table RANK OF COMPANIES IN THE HEPATITIS TESTING MARKET, 2017
    • COMPETITIVE SITUATION AND TRENDS
      • COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
        • Table COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
      • PRODUCT LAUNCHES AND APPROVALS
        • Table PRODUCT LAUNCHES AND APPROVALS, 2015-2018
      • ACQUISITIONS
        • Table ACQUISITIONS, 2015-2018
  • COMPANY PROFILES
    • ABBOTT LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SIEMENS HEALTHINEERS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DIASORIN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • QIAGEN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GRIFOLS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIOMÉRIEUX SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ORTHO CLINICAL DIAGNOSTICS (A PART OF THE CARLYLE GROUP)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • FUJIREBIO, INC. (A PART OF MIRACA GROUP)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report